心肌脂肪酸β-氧化抑制剂研究进展(1)
摘 要 本文综述心肌脂肪酸β-氧化抑制剂的药理作用、临床疗效以及此类药物的研究进展,同时介绍了雷诺嗪和盐酸曲美他嗪在我国的研发现状。关键词脂肪酸β-氧化抑制剂 雷诺嗪 盐酸曲美他嗪 心绞痛
中图分类号:R972.3 文献标识码:A 文章编号:1006-1533(2011)05-0229-03
Recent progress in cardiac muscle fatty acid β-oxidation inhibitor
CAO Jian
(Shanghai Xudong Haipu Pharmaceutical Co.,Ltd,Shanghai,201206)
ABSTRACTThis review is focusing on the pharmacology,clinical efficacy and research progress of cardiac muscle fatty acid oxidation inhibitor. Recent research and development progress as well as marketing of ranolazine and trimetazidine hydrochloride in China are especially introduced.
KEY WORDSfatty acid oxidation inhibitor;ranolazine;trimetazidine hydrochloride;angina
脂肪酸β-氧化抑制剂[1]亦称部分脂肪酸氧化(pFOX)抑制剂 ......
您现在查看是摘要页,全文长 5236 字符。